Alembic Pharma gets USFDA approval to market generic cancer drug ...Middle East

Business Standard - Economy
source : Business Standard ( Middle East ) () 43
Alembic Pharmaceuticals on Wednesday said it has received approval from the US health regulator to market a generic breast cancer drug. The company has received approval from the US Food & Drug Administration (USFDA) to market Docetaxel Injection in multiple dose vials, the drug maker said in a statement. The company's approved product is therapeutically equivalent to Hospira Inc's drug. Docetaxel Injections are indicated for breast cancer, non-small cell lung cancer, castration-resistant prostate cancer, gastric adenocarcinoma and squamous cell carcinoma of head and neck. According to IQVIA data, Docetaxel injection has an estimated market size of USD 11 million in the US market. Shares of

Hence then, the article about alembic pharma gets usfda approval to market generic cancer drug was published today ( ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Alembic Pharma gets USFDA approval to market generic cancer drug )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in Economy
The Storage Solutions Your Battery Hasn’t Heard About (but should)
OILPRICE - before 10 hours & 12 minute
Apirone Unveils Updated Dashboard Built with Comprehensive Design System
PR Newswire - before 4 hours & 13 minute
Home Counties hotspots where London buyers are snapping up properties revealed
INDEPENDENT - before 7 hours & 56 minute
Why Christmas Is the Most Stressful Week for the Diesel Market
OILPRICE - before 8 hours & 9 minute
Gold and Silver Continue to Hit Record Highs
SABA NET - before 11 hour & 51 minute
Bitlock Expands Beyond Telegram as Mobile Wallet Apps Enter Final Testing Phase
PR Newswire - before 3 hours & 30 minute
MediaTek and DENSO Collaborate on Automotive SoCs for Advanced Driver-Assistance Systems
PR Newswire - before hour & 52 minute
Oil Prices Set for Largest Weekly Gain in Three Months
OILPRICE - before 12 minute


Latest News

Oil Prices Set for Largest Weekly Gain in Three Months

before 12 minute

MediaTek and DENSO Collaborate on Automotive SoCs for Advanced Driver-Assistance Systems

before hour & 52 minute

Bitlock Expands Beyond Telegram as Mobile Wallet Apps Enter Final Testing Phase

before 3 hours & 30 minute

Apirone Unveils Updated Dashboard Built with Comprehensive Design System

before 4 hours & 13 minute

Kanazawa University research: High-speed AFM imaging reveals how brain enzyme forms dodecameric ring structure

before 4 hours & 24 minute

TIER IV forms capital and business alliance with JR Central to support regional development through rail and autonomous driving integration

before 7 hours & 18 minute

Home Counties hotspots where London buyers are snapping up properties revealed

before 7 hours & 56 minute

Why Christmas Is the Most Stressful Week for the Diesel Market

before 8 hours & 9 minute

CGTN: Why China's anti-corruption drive never stops

before 9 hours & 31 minute

The Storage Solutions Your Battery Hasn’t Heard About (but should)

before 10 hours & 12 minute

Gold and Silver Continue to Hit Record Highs

before 11 hour & 51 minute

Energy-as-a-Service: A Subscription Trap for Heavy Infrastructure

before 12 hour & 11 minute

Unpacking Copper’s Phantom Deficit

before 14 hour & 17 minute

Why Christmas Is Still a Diesel Stress Test for Energy Markets

before 16 hour & 10 minute

Trump Has a New Auto Loan Tax Break. Here’s Who Could Benefit.

before 16 hour & 11 minute